Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
NeoPhore Ltd logo — Discovering drugs that create neoantigens

NeoPhore Ltd

Discovering drugs that create neoantigens

Founded 2017 United Kingdom Cambridge, United Kingdom 18 employees Series B Total: $33.80M Biotechnology, Health and Wellness

General Information

Company Name NeoPhore Ltd
Founded Year 2017
Location United Kingdom Cambridge, United Kingdom +1
Employees 18
Industries Biotechnology, Health and Wellness
Funding Stage Series B
Social

Get notified when NeoPhore Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NeoPhore Ltd

NeoPhore Ltd is a biotechnology startup headquartered in the United Kingdom, founded in 2017. The company's focus is on creating novel small molecule immuno-oncology therapeutics. Their drugs target genetic mechanisms that have been validated in both clinical and lab studies for promoting neoantigen creation and diversity across various cancers. This innovative approach aims to stimulate the immune system and improve patient outcomes, particularly for those who have not benefited from current cancer immunity therapeutics. NeoPhore recently received a Series B investment on 22nd May 2024, with the renowned pharmaceutical company Bristol-Myers Squibb as one of the investors. Through their groundbreaking work in discovering drugs that create neoantigens, NeoPhore is poised to make a significant impact in the field of cancer treatment.

Taxonomy: immuno-oncology, small molecule therapeutics, neoantigen creation, genetic mechanisms, cancer immunotherapy, immune system stimulation, cancer treatment, drug development, cancer therapy, clinical validation, lab studies, oncology, drug targeting, patient outcomes, cancer research

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series B Unknown 1 Bristol-Myers Squibb 22 May 2024
Series B £9.60M 8
3B Future Health Fund Astellas Venture Management LIFTT Neva SGR
Sixth Element Capital, Simon Fiduciaria +2 		01 Feb 2024
Series B £6.00M 5
3B Future Health Fund Astellas Venture Management
Sixth Element Capital, Claris Ventures +1 		19 Jan 2023
Series B £15.20M 5
3B Future Health Fund Astellas Venture Management
Sixth Element Capital, Claris Ventures +1 		09 Mar 2021
Grant Unknown 1
Innovate UK
27 Apr 2018

View All 6 Funding Rounds

NeoPhore Ltd Alternatives & Competitors

NeoPhore Ltd vs
Apexigen
Apexigen United States

Creating Transformative Immunotherapies for Patients with Cancer

Post Ipo Equity
11 employees
Biopharma, Biotechnology
NeoPhore Ltd vs
NextCure, Inc.
NextCure, Inc. United States

NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel...

Post Ipo Equity
49 employees
Biopharma, Biotechnology
NeoPhore Ltd vs
Oncorus
Oncorus United States

Driving Innovation to Transform Outcomes for Cancer Patients

Post Ipo Debt
6 employees
Biotechnology, Health and Wellness

FAQ About NeoPhore Ltd

Discovering drugs that create neoantigens
NeoPhore Ltd was founded in 2017.
NeoPhore Ltd is headquartered in Cambridge, United Kingdom.
NeoPhore Ltd operates in the following industries: Biotechnology, Health and Wellness.
NeoPhore Ltd has approximately 18 employees.
NeoPhore Ltd has completed 6 funding rounds, raising a total of $33.80M. The latest funding stage is Series B.
Top alternatives and competitors to NeoPhore Ltd include Apexigen, NextCure, Inc., Oncorus, Veana Therapeutics, Inc., Quentis Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NeoPhore Ltd and Apexigen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NeoPhore Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy